CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Vice Chairman & COO bought 1,000 shares at $3.35 ($3,350)
- 4 Open-market buy Chairman and CEO bought 19,500 shares at an average $3.38 ($65,998)
- 8-K/A Event Exhibits
- 10-Q Report Quarterly Report
- 3/A Insider 3/A
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 8-K Event Acquisition or sale completed · Delisting notice · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
- 8-K Event Shareholder vote results
- 8-K Event Other events
Page 18 of 63 · 1,250 filings